| # | Drug | Count |
|---|---|---|
| 0 | PAZOPANIB HYDROCHLORIDE | 17 |
| 1 | DOCETAXEL | 10 |
| 2 | DOCETAXEL ANHYDROUS | 10 |
| 3 | GEMCITABINE | 8 |
| 4 | GEMCITABINE HYDROCHLORIDE | 8 |
| 5 | TRABECTEDIN | 5 |
| 6 | AMLODIPINE | 3 |
| 7 | DOXORUBICIN | 3 |
| 8 | INTERFERON BETA-1A | 3 |
| 9 | LEVONORGESTREL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRABECTEDIN | 5 | 0.0021 |
| 1 | LAROTRECTINIB | 1 | 0.0011 |
| 2 | PAZOPANIB HYDROCHLORIDE | 17 | 0.0006 |
| 3 | RYDAPT | 1 | 0.0005 |
| 4 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 5 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 6 | GEMCITABINE HYDROCHLORIDE | 8 | 0.0001 |
| 7 | DOCETAXEL ANHYDROUS | 10 | 0.0001 |
| 8 | DOCETAXEL | 10 | 0.0001 |
| 9 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 10 | 0.0001 |
| 1 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 6 | Interferon beta [EPC] | 3 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |